Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

Conditions

Schizoaffective Disorder | Schizophrenia

What is the purpose of this trial?


Participation Guidelines

Age:
18 Years - 65 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Stanley Medical Research Institute
Yale University
Dates:
February 2009
Last Updated:
April 1, 2014
Study HIC#:
0710003164

Clinicaltrials.gov ID: NCT00588731